ArticleGlobal epidemiology2025
Mortality trends associated with hypertension and atrial fibrillation: A CDC WONDER data analysis.
Article in Global epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- National Mortality Trends, Disparities, and Forecasted Burden of Atrial Fibrillation and Heart Failure with Underlying Ischemic Heart Disease Among Older Adults in the United States, 1999-2023.Journal of epidemiology and global health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension (HTN) and atrial fibrillation (AF) are prevalent cardiovascular disorders that significantly increase the risk of serious complications such as stroke and heart failure, leading to elevated mortality rates. Despite the established relationship between HTN and AF, there is a lack of comprehensive evidence on mortality trends and disparities across various demographic groups in the United States. Objectives: This study aims to analyze the nationwide mortality trends due to HTN-AF from 1999 to 2020 and to identify disparities across different demographics. The goals include understanding the impact of HTN-AF on public health and informing targeted screening and therapeutic strategies. Methods: Data on mortality figures related to HTN and AF were obtained from the Centers for Disease Control and Prevention's (CDC) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database. The analysis included age-adjusted mortality rates (AAMR) and crude mortality rates (CMR) stratified by gender, age, race/ethnicity, and geographic regions. The Joinpoint software was used to analyze temporal trends in age-adjusted mortality rate (AAMR). Data were obtained from publicly available multiple causes of death records via the CDC WONDER database. Results: From 1999 to 2020, the AAMR due to hypertension-attributable factors rose sharply from 2.89 to 23.98 per 100,000 (APC: 4.8 %). Males had higher AAMRs than females, with Black or African American populations seeing the steepest increases. Regionally, the West had the highest AAMR, and rural areas experienced the most significant rise, with micropolitan areas showing the highest APC. Conclusion: HTN-AF mortality has been increasing steadily across all genders, races, and regions. The study underscores the importance of improving healthcare policies, bridging coverage gaps, and enhancing education and awareness to curb these alarming trends. Addressing the disparities in healthcare access and promoting cardiovascular health initiatives are crucial for reducing HTN-AF-related mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.